State-of-the-art bioavailability in VAD construction
Since 2018, having left clinical practice, I’ve devoted myself full-time to the VADproject (“main project” of ARC) for the construction of a pulsatile-flow device. This instrument supports hearts in contractile force deficit, regardless of pathogenesis, while the patient is awaiting healing, heart transplant or, as a last resort, serves as destination therapy if no other therapies are feasible.
There are many VAD instruments on the market around the world, but all work on a continuous-flow mechanism: they are very well engineered yet they produce damage to the organism which is very severe and irreparable.
The construction of a VAD, the applications of which have been studied by me for many years, integrates knowledge and the solution to many problems, such as shape, construction materials, weight, valves, membranes, frequent episodes of infection, blood compatibility and the function of all organs, as well as the vibrations and noise that may occur when the device is in operation.
A safe and reliable system
Knowledge of the aforementioned problems allowed me to construct a safe and reliable system: a wholly bioavailabledevice, along with the possibility to be made in variable sizes which could be adapted to patients both large and small, including pediatric.
The complexity of the device includes technical and constructive particularities, that I specifically intend for use in future projects for other cardio-vascular device applications.
US Patent
3D Model in reverse engineering
The model was studied from the US Patent and a 3D model in reverse engineering was generated. Equipment for the “Bench Test” phase has of course been set up, which will allow for both the initial acute assessments as well as long-term testing. Structural and material upgrading have been accounted for in line with the pertinent GANTT diagram. I have been supported in these efforts by my Team, formed of eight Cardio-Surgical and seven Cardiologist Colleagues, all of proven competence and experience in this field.
Startup of truly bioavailable instruments
In 2022, this tight-knit Team, with the chief presence of Prof. Paolo Pantaleo, collaborated with engineers and mathematicians to develop and patent (as a “side project” of ARC), the software ARINAS: the first of its kind in the world, using Artificial Intelligence, to assist the study and repair of Mitral Valves.
My years of experience in this field has given me the opportunity to collaborate with Professionals and Companies in the Private Sector, with highly valued and specialized skills for the study and construction of instruments that are technically at “the top” and consequently competitive at the international level.
Companies
AZZOCOR RESEARCH CENTRE
AzzoCor Research Centre Ltd Edinburgh, Scotland, UK
SPONSORS
PulsaHeart Fintech Ltd London, UK
Pulsa Swiss SA Lugano, CH
ENGINEERING
Futura Engineering s.r.l.
Cerbara di Città di Castello (PG), Italia
PRODUCTION LABS
Termotiberina s.r.l. Città di Castello (PG), Italia
This website uses cookies to improve the user experience. By using our site you consent to this use in accordance with the Cookie Policy.
